Effects of Iron Therapy in Heart Failure With Preserved Ejection Fraction and Iron Deficiency (PREFER-HF)
Status:
Unknown status
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate whether the administration of iron to patients with
heart failure and preserved ejection fraction results in an improvement of symptoms and
functional class, in addition to evaluating whether oral iron is equivalent to intravenous
iron to achieve this improvement.